Company Information
- Type:
- Company
- Country:
- Bangladesh
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 19 August 2004 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Engagements
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 26-Aug-2024 | 2024 Communication on Progress | Submitted |
| 12-Mar-2022 | Communication on Progress | Active |
| 12-Mar-2021 | Communication on Progress (Jan-Dec 2020) | Active |
| 12-Mar-2020 | Communication on Progress (Jan-Dec_2019) | Active |
| 13-Mar-2019 | Communication on Progress (Jan-Dec 2018) | Active |
| 13-Mar-2018 | Communication on Progress (Jan-Dec 2017) | Active |
| 14-Mar-2017 | Communication on Progress (Jan-Dec 2016) | Active |
| 14-Mar-2016 | Communication on Progress Jan-Dec 2015 | Active |
| 13-Mar-2016 | Grace Letter | Not applicable |
| 12-Mar-2015 | Communication on Progress 2014 | Active |
| 12-Mar-2014 | COP-Jan-Dec 2013 | Active |
| 14-Mar-2013 | Communication on Progress 2013 | Active |
| 15-Mar-2012 | Communication on Progress | Active |
| 16-Mar-2011 | 2010 Communication on Progress | Active |
| 16-Mar-2010 | 2010 Communication on Progress | Not applicable |
| 02-Mar-2009 | Communication On Progress - Square Pharma | Not applicable |
| 28-Jul-2007 | UN Global Compact COP - Square Pharmaceuticals Ltd, Bangladesh | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.